Results 31 to 40 of about 3,613,662 (378)
Clinical Infectious Diseases, 2023 BACKGROUND The Infectious Diseases Society of America (IDSA) is committed to providing up-to-date guidance on the treatment of antimicrobial-resistant infections.
P. Tamma +5 more
semanticscholar +1 more source
The Pan African Medical Journal, 2015 Nous rapportons deux cas d'infection à Pseudomonas aeruginosa: un cas de méningite et un cas d'infection urinaire. Les auteurs rappellent qu'à côté des étiologies classiques des méningites et des infections urinaires, des germes résistants comme ...
Savadogo Mamoudou +2 more
doaj +1 more source
LasB, ExoS and Nan1 genes as potential predictors of site-specific Pseudomonas aeruginosa pathogenicity in nosocomial isolates [PDF]
Microbes and Infectious DiseasesBackground: Pseudomonas aeruginosa is an opportunistic pathogen that represents a global public health threat. Immunocompromised hosts and cystic fibrosis patients are primarily susceptible to high morbidity and mortality due to pulmonary tract ...
Maii Shams Eldeen +4 more
doaj +1 more source
Using a phenotypic method to confirm the presence of the efflux pump associated with resistance to ciprofloxacin in Pseudomonas aeruginosa isolated from skin samples [PDF]
بیولوژی کاربردی, 2019 Introduction One of the most important causes of nosocomial infections in patients with skin infections is Pseudomonas aeruginosa. The occurrence of antibiotic resistance with various mechanisms is one of the problems in treating these patients.
Ali Rahmati, Mohammad Reza zolfaghary
doaj
Evaluation of empiric therapy appropriateness, resistance patterns, and mortality in Pseudomonas aeruginosa infections in Jordan [PDF]
Exploration of MedicineAim: This study aimed to investigate the susceptibility patterns of Pseudomonas aeruginosa strains, examine infection characteristics, and evaluate the appropriateness of empiric antibiotic therapy.
Savana Sobh +3 more
doaj +1 more source
Pseudomonas infection in CF [PDF]
Thorax, 2000 Elborn et al 1 have attempted to address the important question of whether it is better to treat patients with cystic fibrosis (CF) who have chronic Pseudomonas aeruginosa infection with intravenous antibiotics on the basis of symptoms or to treat them electively, and found no significant difference between their groups.
Rob Roseby, John Massie
openaire +2 more sources
Phage therapy against Pseudomonas aeruginosa infections in a cystic fibrosis zebrafish model
Scientific Reports, 2019 Cystic fibrosis (CF) is a hereditary disease due to mutations in the CFTR gene and causes mortality in humans mainly due to respiratory infections caused by Pseudomonas aeruginosa. In a previous work we used phage therapy, which is a treatment with a mix
M. Cafora +7 more
semanticscholar +1 more source
Vaccination to Prevent Pseudomonas aeruginosa Bloodstream Infections
Frontiers in Microbiology, 2022 The bacterium Pseudomonas aeruginosa (Pa) is ubiquitous in the environment and causes opportunistic infections in humans. Pa is increasingly becoming one of the most difficult to treat microorganisms due to its intrinsic and acquired resistance to ...
Robert J. Hart, Lisa A. Morici
doaj +1 more source
Influence of the lung microbiome on antibiotic susceptibility of cystic fibrosis pathogens [PDF]
, 2019 The lungs of patients with cystic fibrosis (CF) are colonised by a microbial community comprised of pathogenic species, such as Pseudomonas aeruginosa and Staphylococcus aureus, and microorganisms that are typically not associated with worse clinical ...
Coenye, Tom +3 more
core +1 more source
Science Translational Medicine, 2019 Pseudomonas strains that produce filamentous bacteriophage are associated with chronic infection and increased antibiotic resistance in patients with cystic fibrosis. Infection-boosting phage Chronic Pseudomonas aeruginosa infection is common in patients
Elizabeth B. Burgener +14 more
semanticscholar +1 more source